author-photo

Jeremy J.W. Chen

National Chung Hsing University
National Taiwan University

180

Papers

7297

Citations

Citation Trend

Filter By

Papers (180) Sort By

Journal Conference Others

185TiP A phase Ib dose-escalation study evaluating trastuzumab deruxtecan (T-DXd) and durvalumab in combination with chemotherapy as first-line treatment in patients with advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) and HER2 overexpression (DESTINY-Lung03)

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naïve Advanced EGFR-Mutant Lung Adenocarcinoma Patients.

2021 OncoTargets and Therapy
Show All
- Source
- Cite
- Save
Citations (1)
Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M.

2021 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (0)
ANA positivity and complement level in pleural fluid are potential diagnostic markers in discriminating lupus pleuritis from pleural effusion of other aetiologies.

2021 Lupus science & medicine
Show All
- Source
- Cite
- Save
Citations (0)
The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M.

2021 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (1)
The Clinical Outcomes of Different First-Line EGFR-TKIs plus Bevacizumab in Advanced EGFR-mutant Lung Adenocarcinoma.

2021 Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (0)
Paired-like homeodomain 2B contributes to tumour progression and anti-autophagy in human lung cancer.

2021 American Journal of Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts.

2021 Theranostics
Show All
- Source
- Cite
- Save
Citations (0)
MITF functions as a tumor suppressor in non-small cell lung cancer beyond the canonically oncogenic role.

2020
Show All
- Source
- Cite
- Save
Citations (2)
Landscape of Mitochondria Genome and Clinical Outcomes in Stage 1 Lung Adenocarcinoma

2020 Cancers
Show All
- Source
- Cite
- Save
Citations (3)